Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 7/2021

29.01.2021 | Brief Report

Development and standardization of a specific real-time PCR assay for the rapid detection of Candida auris

verfasst von: Ahmad Ibrahim, Sophie Alexandra Baron, Hanane Yousfi, Linda Hadjadj, Rym Lalaoui, Serge Morand, Jean-Marc Rolain, Fadi Bittar

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 7/2021

Einloggen, um Zugang zu erhalten

Abstract

Candida auris is an emerging multiresistant pathogen causing nosocomial fungal infection. Specific detection and identification are necessary. Our goal is to develop a new qPCR system that enables rapid detection of C. auris, based on a GPI (glycosyl-phosphatidylinositol) protein-encoding gene. This system is reproducible and sensitive with a limit of detection of 13 C. auris CFU/qPCR reaction. The 100% specificity of this system is confirmed on 2073 clinical and environmental samples, 50 different bacterial species, and 9 Candida spp. (70 strains). This system is suitable to correctly identify C. auris infections and to trace its source.
Literatur
1.
Zurück zum Zitat Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A et al (2015) Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization–time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. J Clin Microbiol 53(6):1823–1830CrossRef Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A et al (2015) Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization–time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. J Clin Microbiol 53(6):1823–1830CrossRef
2.
Zurück zum Zitat Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP et al (2017) Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 64(2):134–140CrossRef Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP et al (2017) Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 64(2):134–140CrossRef
3.
Zurück zum Zitat Chow NA, de Groot T, Badali H, Abastabar M, Chiller TM, Meis JF (2019) Potential fifth clade of Candida auris, Iran, 2018. Emerg Infect Dis 25(9):1780CrossRef Chow NA, de Groot T, Badali H, Abastabar M, Chiller TM, Meis JF (2019) Potential fifth clade of Candida auris, Iran, 2018. Emerg Infect Dis 25(9):1780CrossRef
4.
Zurück zum Zitat Osei Sekyere J (2018) Candida auris: a systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen. Microbiologyopen 7(4):e00578CrossRef Osei Sekyere J (2018) Candida auris: a systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen. Microbiologyopen 7(4):e00578CrossRef
5.
Zurück zum Zitat Sherry L, Ramage G, Kean R, Borman A, Johnson EM, Richardson MD, Rautemaa-Richardson R (2017) Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris. Emerg Infect Dis 23(2):328CrossRef Sherry L, Ramage G, Kean R, Borman A, Johnson EM, Richardson MD, Rautemaa-Richardson R (2017) Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris. Emerg Infect Dis 23(2):328CrossRef
6.
Zurück zum Zitat Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, Litvintseva AP (2017) Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol 55(10):2996–3005CrossRef Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, Litvintseva AP (2017) Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol 55(10):2996–3005CrossRef
7.
Zurück zum Zitat Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H (2009) Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 53(1):41–44CrossRef Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H (2009) Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 53(1):41–44CrossRef
8.
Zurück zum Zitat Chowdhary A, Sharma C, Meis JF (2017) Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog 13(5):e1006290CrossRef Chowdhary A, Sharma C, Meis JF (2017) Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog 13(5):e1006290CrossRef
9.
Zurück zum Zitat Fasciana T, Cortegiani A, Ippolito M, Giarratano A, Di Quattro O, Lipari D et al (2020) Candida auris: an overview of how to screen, detect, test and control this emerging pathogen. Antibiotics 9(11):778CrossRef Fasciana T, Cortegiani A, Ippolito M, Giarratano A, Di Quattro O, Lipari D et al (2020) Candida auris: an overview of how to screen, detect, test and control this emerging pathogen. Antibiotics 9(11):778CrossRef
10.
Zurück zum Zitat Cortegiani A, Misseri G, Fasciana T, Giammanco A, Giarratano A, Chowdhary A (2018) Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris. J Intensive Care 6(1):69CrossRef Cortegiani A, Misseri G, Fasciana T, Giammanco A, Giarratano A, Chowdhary A (2018) Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris. J Intensive Care 6(1):69CrossRef
11.
Zurück zum Zitat Vatanshenassan M, Boekhout T, Meis JF, Berman J, Chowdhary A, Ben-Ami R et al (2019) Candida auris identification and rapid antifungal susceptibility testing against echinocandins by MALDI-TOF MS. Front Cell Infect Microbiol 9:20CrossRef Vatanshenassan M, Boekhout T, Meis JF, Berman J, Chowdhary A, Ben-Ami R et al (2019) Candida auris identification and rapid antifungal susceptibility testing against echinocandins by MALDI-TOF MS. Front Cell Infect Microbiol 9:20CrossRef
12.
Zurück zum Zitat Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlin DS (2017) Rapid and accurate molecular identification of the emerging multidrug-resistant pathogen Candida auris. J Clin Microbiol 55(8):2445–2452CrossRef Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlin DS (2017) Rapid and accurate molecular identification of the emerging multidrug-resistant pathogen Candida auris. J Clin Microbiol 55(8):2445–2452CrossRef
13.
Zurück zum Zitat Khan Z, Ahmad S, Al-Sweih N, Joseph L, Alfouzan W, Asadzadeh M (2018) Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait. PLoS One 13(4):e0195743CrossRef Khan Z, Ahmad S, Al-Sweih N, Joseph L, Alfouzan W, Asadzadeh M (2018) Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait. PLoS One 13(4):e0195743CrossRef
14.
Zurück zum Zitat Ruiz-Gaitán AC, Fernández-Pereira J, Valentin E, Tormo-Mas MA, Eraso E, Pemán J, de Groot PW (2018) Molecular identification of Candida auris by PCR amplification of species-specific GPI protein-encoding genes. Int J Med Microbiol 308(7):812–818CrossRef Ruiz-Gaitán AC, Fernández-Pereira J, Valentin E, Tormo-Mas MA, Eraso E, Pemán J, de Groot PW (2018) Molecular identification of Candida auris by PCR amplification of species-specific GPI protein-encoding genes. Int J Med Microbiol 308(7):812–818CrossRef
15.
Zurück zum Zitat Sexton DJ, Kordalewska M, Bentz ML, Welsh RM, Perlin DS, Litvintseva AP (2018) Direct detection of emergent fungal pathogen Candida auris in clinical skin swabs by SYBR green-based quantitative PCR assay. J Clin Microbiol 56(12):e01337-18 Sexton DJ, Kordalewska M, Bentz ML, Welsh RM, Perlin DS, Litvintseva AP (2018) Direct detection of emergent fungal pathogen Candida auris in clinical skin swabs by SYBR green-based quantitative PCR assay. J Clin Microbiol 56(12):e01337-18
16.
Zurück zum Zitat Arastehfar A, Fang W, Daneshnia F, Al-Hatmi AM, Liao W, Pan W et al (2019) Novel multiplex real-time quantitative PCR detecting system approach for direct detection of Candida auris and its relatives in spiked serum samples. Future Microbiol 14(1):33–45CrossRef Arastehfar A, Fang W, Daneshnia F, Al-Hatmi AM, Liao W, Pan W et al (2019) Novel multiplex real-time quantitative PCR detecting system approach for direct detection of Candida auris and its relatives in spiked serum samples. Future Microbiol 14(1):33–45CrossRef
17.
Zurück zum Zitat Leach L, Zhu Y, Chaturvedi S (2018) Development and validation of a real-time PCR assay for rapid detection of Candida auris from surveillance samples. J Clin Microbiol 56(2) Leach L, Zhu Y, Chaturvedi S (2018) Development and validation of a real-time PCR assay for rapid detection of Candida auris from surveillance samples. J Clin Microbiol 56(2)
18.
Zurück zum Zitat Ahmad A, Spencer JE, Lockhart SR, Singleton S, Petway DJ, Bagarozzi DA Jr, Herzegh OT (2019) A high-throughput and rapid method for accurate identification of emerging multidrug-resistant Candida auris. Mycoses 62(6):513–518CrossRef Ahmad A, Spencer JE, Lockhart SR, Singleton S, Petway DJ, Bagarozzi DA Jr, Herzegh OT (2019) A high-throughput and rapid method for accurate identification of emerging multidrug-resistant Candida auris. Mycoses 62(6):513–518CrossRef
19.
Zurück zum Zitat Lima A, Widen R, Vestal G, Uy D, Silbert S (2019) A TaqMan probe-based real-time PCR assay for the rapid identification of the emerging multidrug-resistant pathogen Candida auris on the BD Max system. J Clin Microbiol 57(7):e01604–e01618CrossRef Lima A, Widen R, Vestal G, Uy D, Silbert S (2019) A TaqMan probe-based real-time PCR assay for the rapid identification of the emerging multidrug-resistant pathogen Candida auris on the BD Max system. J Clin Microbiol 57(7):e01604–e01618CrossRef
20.
Zurück zum Zitat Olaitan AO, Thongmalayvong B, Akkhavong K, Somphavong S, Paboriboune P, Khounsy S et al (2015) Clonal transmission of a colistin-resistant Escherichia coli from a domesticated pig to a human in Laos. J Antimicrob Chemother 70(12):3402–3404PubMed Olaitan AO, Thongmalayvong B, Akkhavong K, Somphavong S, Paboriboune P, Khounsy S et al (2015) Clonal transmission of a colistin-resistant Escherichia coli from a domesticated pig to a human in Laos. J Antimicrob Chemother 70(12):3402–3404PubMed
21.
Zurück zum Zitat Olaitan AO, Diene SM, Kempf M, Berrazeg M, Bakour S, Gupta SK et al (2014) Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. Int J Antimicrob Agents 44(6):500–507CrossRef Olaitan AO, Diene SM, Kempf M, Berrazeg M, Bakour S, Gupta SK et al (2014) Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. Int J Antimicrob Agents 44(6):500–507CrossRef
22.
Zurück zum Zitat Lalaoui R, Djukovic A, Bakour S, Sanz J, Gonzalez-Barbera EM, Salavert M et al (2019) Detection of plasmid-mediated colistin resistance, mcr-1 gene, in Escherichia coli isolated from high-risk patients with acute leukemia in Spain. J Infect Chemother 25(8):605–609CrossRef Lalaoui R, Djukovic A, Bakour S, Sanz J, Gonzalez-Barbera EM, Salavert M et al (2019) Detection of plasmid-mediated colistin resistance, mcr-1 gene, in Escherichia coli isolated from high-risk patients with acute leukemia in Spain. J Infect Chemother 25(8):605–609CrossRef
23.
Zurück zum Zitat Casadevall A, Kontoyiannis DP, Robert V (2019) On the emergence of Candida auris: climate change, azoles, swamps, and birds. MBio 10(4):e01397–e01319CrossRef Casadevall A, Kontoyiannis DP, Robert V (2019) On the emergence of Candida auris: climate change, azoles, swamps, and birds. MBio 10(4):e01397–e01319CrossRef
24.
Zurück zum Zitat Misseri G, Ippolito M, Cortegiani A (2019) Global warming “heating up” the ICU through Candida auris infections: the climate changes theory. Crit Care 23(1):1–2CrossRef Misseri G, Ippolito M, Cortegiani A (2019) Global warming “heating up” the ICU through Candida auris infections: the climate changes theory. Crit Care 23(1):1–2CrossRef
25.
Zurück zum Zitat Cortegiani A, Misseri G, Giarratano A, Bassetti M, Eyre D (2019) The global challenge of Candida auris in the intensive care unit. Crit Care 23(1):150 Cortegiani A, Misseri G, Giarratano A, Bassetti M, Eyre D (2019) The global challenge of Candida auris in the intensive care unit. Crit Care 23(1):150
Metadaten
Titel
Development and standardization of a specific real-time PCR assay for the rapid detection of Candida auris
verfasst von
Ahmad Ibrahim
Sophie Alexandra Baron
Hanane Yousfi
Linda Hadjadj
Rym Lalaoui
Serge Morand
Jean-Marc Rolain
Fadi Bittar
Publikationsdatum
29.01.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 7/2021
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-021-04176-8

Weitere Artikel der Ausgabe 7/2021

European Journal of Clinical Microbiology & Infectious Diseases 7/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.